Cerus reported $20.36M in Selling and Administration Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Atrion ATRI:US 6.92M 292K
Cerulean Pharma CERU:US $ 2.24M 413.69K
Cerus CERS:US $ 20.36M 599K
Cytori Therapeutics CYTX:US $ 1.99M 521K
GRIFOLS GRF:SM 249.86M 7.28M
Haemonetics HAE:US $ 74.42M 4.64M
Meridian Bioscience VIVO:US $ 19.72M 1.55M
Nuvasive NUVA:US $ 146.06M 11.34M
Orasure Technologies OSUR:US $ 26.38M 4.97M
Quidel QDEL:US $ 67.89M 8.65M
Sientra SIEN:US 19.92M 1.9M
Staar Surgical STAA:US $ 29.19M 1.1M
Terumo 4543:JP 62.08B 3.94B